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Hepatorenal failure, a well-recognized complication 
of established liver disease, is characterized by early 
renal hemodynamic changes (vasoconstriction) before 
clinically recognized kidney disease. This renal vaso- 
constriction (increased renal vascular resistance) 
should be detectable noninvasively by Doppler ultra- 
sonography. We studied whether renal Doppler ultra- 
sonography detects abnormalities in patients with 
nonazotemic liver disease and its prognostic value for 
subsequent kidney status. We observed by renal 
Doppler ultrasonography 180 patients who had liver 
disease without azotemia. A simple parameter, re- 
sistive index, was derived for each subject on the basis 
of Doppler waveform analysis. Traditional parameters 
used to assess patients with liver disease were also 
recorded at the time of Doppler ultrasonography. 
Subsequent kidney outcomes were kidney dysfunction 
(doubling of initial creatinine level to 1.5 mgldl 1133 
pmol/Ll) or more and the presence or absence of the 
hepatorenal syndrome. Abnormal results of Doppler 
examinations (elevated resistive index) were seen in 76 
(42%) of the 180 patients. Kidney dysfunction de- 
veloped in 55% (42/76) of the patients with an elevated 
resistive index and 6% (6/104) of those with normal 
results of Doppler study (p < 0.00005). Hepatorenal 
syndrome developed in 26% (20/76) of subjects with an 
elevated resistive index and 1% (1/104) of those with a 
normal resistive index (p < 0.00005). Cox regression 
analysis identified resistive index as a significant 
independent predictor of subsequent hepatorenal syn- 
drome (p < 0.00005) and kidney dysfunction (p < 
0.00005). Renal duplex Doppler ultrasonography can 
noninvasively identify a subgroup of nonazotemic 
patients with liver disease that is at significantly 
higher risk for subsequent development of kidney 
dysfunction and the hepatorenal syndrome. (HEPA- 
TOLOGY 1994;20:362-369.) 
Kidney dysfunction commonly develops in patients 
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with established liver disease (1-3). In its most severe 
form this ludney dysfunction is termed the hepatorenal 
syndrome, which has been defined as unexplained 
kidney failure in a patient with liver disease who does 
not have clinical, laboratory or anatomic evidence of 
other known causes of kidney failure (1). The pro- 
gressive kidney dysfunction that accompanies liver 
disease is generally considered to be functional in nature 
because consistent pathologic changes are absent, be- 
cause the kidney failure can be reversed with timely liver 
transplantation, and because kidneys in patients with 
the hepatorenal syndrome can be successfully trans- 
planted into patients with normal livers (4-6). 
Renal hemodynamic changes begin early in the course 
of liver disease-related functional kidney failure, even 
before changes in serum creatinine concentration are 
detectable (2, 7-10). The hallmark change is intense 
intrarenal vasoconstriction (1, 8, 9). Th' is vasocon- 
striction is associated with a reduced renal plasma flow 
and an elevated renal arterial vascular resistance that 
may precede clinically recognized kidney dysfunction by 
weeks or months. Although the precise cause of the renal 
vasoconstriction remains elusive and is likely multifac- 
torial (ll), a state of elevated renal vascular resistance 
is present in many nonazotemic patients with liver 
disease. These patients may be at greater risk for 
subsequent development of overt hepatorenal syndrome 
(2, 7). 
Duplex Doppler ultrasonography is a widely used 
noninvasive method to assess vascular patency and 
blood flow in many sites. Duplex Doppler can be used to 
assess vascular resistance in the small renal intraparen- 
chymal vessels through simple analysis of the Doppler 
waveform by a parameter termed the resistive index (RI) 
(12). An elevated RI (reflecting intrarenal vasocon- 
striction) has been observed in various conditions 
associated with elevated renal vascular resistance such 
as kidney obstruction (131, acute tubular necrosis (141, 
renal vein thrombosis (15) and the hemolytic-uremic 
syndrome (16) and should be detectable in liver disease- 
related functional kidney failure. 
In a previous pilot study in patients before and after 
liver transplantation we found Doppler analysis helpful 
in predicting subsequent hdney status and to some 
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FIG. 1. Normal intrarenal Doppler waveform showing determination of RI. S, Peak systole; D, minimum diastole. RI = (S - DYS. 
extent in predicting posttransplantation morbidity (17). 
Another recent study found elevated RIs in more than 
half of nonazotemic patients with significant cirrhosis 
but did not follow the patients to assess the chance of the 
development of overt kidney dysfunction (18). The goal 
of the current study was to assess the prognostic value 
of duplex Doppler ultrasonography in a large population 
of nonazotemic patients with liver disease. Early iden- 
tification of those patients with established liver disease 
who are a t  particular risk for the development of the 
hepatorenal syndrome may be beneficial both because 
clinical management may be modified to avoid other 
nephrotoxins (drugs, radiographic contrast) and because 
overt kidney failure has been identified as an inde- 
pendent risk factor for outcome in liver transplantation 
(19). 
PATIENTS AND METHODS 
Patients were included in this study population if they had 
been evaluated for known liver disease at  our institution’s liver 
clinic and did not have clinical azotemia (serum creatinine 
concentration I 1.5 mg/dl [133 pmol/L]) and if a minimum 
period of 4 mo of follow-up clinical and laboratory data was 
available. Three hundred seven patients were initially prospec- 
tively observed in our liver clinics over a 20-mo period. Of 
these, 67 were excluded because their serum creatinine 
concentration at  presentation exceeded 1.5 mg/dl. An addi- 
tional 60 nonazotemic patients were excluded because no 
follow-up clinical and laboratory data were available for a 
minimum of 4 mo to assess subsequent kidney status. 
The remaining 180 patients constitute our study popu- 
lation. All of these patients with liver disease had a serum 
creatinine concentration of 1.5 mg/dl (133 pmol/L) or less at 
the time of duplex Doppler ultrasonography and a minimum of 
4 mo clinical follow-up unless hepatorenal syndrome developed 
before this minimum follow-up time. The clinical character- 
istics of the study population are shown in Table 1. 
Multiple clinical and laboratory parameters were assessed at 
the time of the duplex Doppler ultrasound examination. The 
patient’s systolic and diastolic blood pressures were recorded, 
allowing for calculation of mean arterial pressure [Diastolic 
pressure + Y3 (Systolic - diastolic)]. Laboratory values in- 
cluded serum albumin (level grams per deciliter), serum 
bilirubin level (milligrams per deciliter), prothrombin time 
(PT, seconds), serum sodium concentration (millimoles per 
liter) and serum creatinine concentration (milligrams per 
deciliter). Ascites was assessed by sonography and graded as 
absent, mild or moderate to severe. Sixty-three patients had no 
ascites, and the remaining 117 patients did have ascites. 
Encephalopathy was clinically assessed and classified as 
absent, grade 1 to 2 encephalopathy or grade 3 to 4 encepha- 
lopathy. Patient age was also recorded in years at  time of 
Doppler ultrasound study. 
In addition to considering the above parameters indi- 
vidually, we combined five factors (serum albumin, serum 
bilirubin, ascites, encephalopathy and PT) to grade the 
severity of disease on the basis of the Pugh modification of the 
Child-Turcotte classification (20). 
For each patient the zero time was defined as the day of the 
duplex Doppler ultrasound study. The number of days of 
follow-up in each patient was recorded. End points for 
follow-up were, where applicable, death, hepatorenal syn- 
drome, day of liver transplantation (no data on kidney status 
after liver transplantation were included in this study) and last 
day of normal follow-up. One hundred sixteen patients in all 
underwent liver transplantation during the study period. If 
kidney status remained stable, a minimum of 4 mo follow-up 
was required for inclusion in the study. The two kidney status 
outcome changes identified were kidney dysfunction and 
hepatorenal syndrome. We defined kidney dysfunction as a 
doubling of the initial creatinine level (recorded at  time of 
Doppler ultrasonography) to a level of 1.5 mg/dl (133 Fmol/L) 
or greater. We used this outcome parameter to identify all 
patients in whom significant kidney disease developed during 
the follow-up period. Thus the kidney dysfunction group 
includes, in addition to the patients with overt hepatorenal 
syndrome, those patients in whom kidney deterioration de- 
veloped that was not definitely categorized as representing 
hepatorenal syndrome. We defined hepatorenal syndrome 
clinically on the basis of usual criteria: kidney failure devel- 
oping without apparent cause in a patient with liver disease, 
urine sodium level more than 20 mmol/L, benign urinary 
sediment, oliguria ( < 400 ml/day) and lack of response to fluid 
challenge as proved by central venous monitoring (1, 3, 11). 
All patients had a prospectively obtained Doppler ultra- 
sound study with the results blinded to those managing the 
clinical follow-up in these patients. The duplex Doppler 
ultrasonography technique is summarized as follows (12): in 
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FIG. 2. Survival-type curves demonstrating probability of kidney dysfunction (RD) developing or not developing over time. Dashed line, 
Patients with normal renal RI; solid line, patients with abnormal renal RI. Difference between curves is statistically significant (p < 0.00005). 
Number of patients in follow-up group was 128 at 172 days, 106 at 258 days, 81 at 344 days and 31 at 430 days. 
each kidney, real-time ultrasound examinations were per- 
formed with a 3.5-MHz transducer (model 128; Acuson, 
Mountain View, CA) or a 3-MHz transducer (model UM 8 or 9; 
Advanced Technology Laboratories, Bothell, WA), and a pulsed 
Doppler evaluation of intrarenal arteries was performed. 
Multiple Doppler signal tracings and a standard gray-scale 
examination of the kidney were recorded on film. Doppler 
signals were, in general, obtained from arcuate arteries at the 
corticomedullary junction, interlobar arteries along the border 
of medullary pyramids or both. The Doppler waveforms were 
made on the lowest frequency-shift range possible without 
aliasing. This procedure maximized the size of the Doppler 
spectrum and decreased the percentage error in the measure- 
ments. In addition, we used the lowest possible wall filter for 
each ultrasound scanner. Doppler sample volume was set at 2 
to 5 mm. 
Duplex Doppler ultrasound examinations required 15 min 
or less in most patients. Movement of the patient and inability 
of the patient to suspend respiration temporarily were the 
most common causes of a more prolonged, difficult exami- 
nation. The RI [(Peak systolic frequency shift - Minimum 
diastolic frequency shift )/Peak systolic frequency shift] was 
determined by hand measurement of the hard copy with 
calipers (Fig. 1). The RI for each kidney was calculated as an 
average value obtained from three to five waveforms recorded 
in three different regions of the kidney. Subsequently, a mean 
renal RI was calculated for each patient (average of both 
kidneys). The person performing the duplex Doppler ultra- 
sound examinations and renal RI measurements was blinded 
to the patients’ clinical status and laboratory results. In 
addition to the actual RI value being recorded, it was classified 
as normal or abnormal on the basis of a threshold RI value. On 
the basis of multiple prior studies (12, 13, 16) an RI of 0.70 or 
more was considered abnormal (indicative of elevated renal 
vascular resistance and renal vasoconstriction). In general, the 
amount of variation in RI for different sites within a particular 
kidney was small, averaging 3.5% in patients with a normal RI 
and 4.3% in those with an elevated RI. Although our study did 
not primarily seek to evaluate longitudinal changes in RI for a 
given patient, in a small subset of patients (n = 20) a second 
Doppler examination was performed less than 1 wk after the 
initial study. The mean RI difference for these two studies was 
3.2% with no follow-up study result differing by more than 5% 
from the original RI. 
Analysis of RI vs. development of kidney dysfunction or 
hepatorenal syndrome used the x2 test. To assess the prog- 
nostic value of individual variables in our study, we used a Cox 
proportional hazard regression analysis (BMDP program; 
BMDP Statistical Software, Inc., Los Angeles, CAI. This 
method was used to determine whether RI had significant 
predictive value above and beyond the commonly used factors 
to assess severity and prognosis in patients with liver disease. 
The covariables chosen were age, serum albumin level, serum 
bilirubin level, serum sodium level, PT, serum creatinine 
concentration, mean arterial pressure, ascites grade and 
encephalopathy grade. Estimated survival-type function 
curves were derived for RI status controlling for covariants 
with respect to the outcomes of hepatorenal syndrome and 
kidney dysfunction. These results were depicted graphically. 
Differences between the elevated RI and normal RI groups 
were analyzed with unpaired Student’s t-test where appro- 
priate. 
The duplex Doppler ultrasonography protocol and study 
were approved by our local institutional review board. Patients 
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were already undergoing clinically requested hepatic vessel 
Doppler sonograms and consented to the renal vessel studies. 
RESULTS 
Of the 180 patients with established liver disease who 
fulfilled the study entry criteria including serum creat- 
inine level of 1.5 mg/dl or less, 76 (42%) had an elevated 
RI (indicative of renal vasoconstriction). The remaining 
104 patients (58%) had a normal renal RI. 
Laboratory evidence of kidney dysfunction developed 
in 48 (27%) patients during follow-up. Forty-two of these 
48 patients had an elevated renal RI. In 55% (42/76) of 
patients with elevated RIs, kidney dysfunction de- 
veloped, whereas subsequent kidney dysfunction de- 
veloped in only 6% (6/104) of those with normal RIs 
(p < 0.00005). Cox regression analysis for kidney dys- 
function with the use of the individual parameters 
previously identified in this study found that RI 
(p < 0.00005), bilirubin level (p < O.OOOl),  ascites 
(p < 0.001) and age (p < 0.05) were significant pre- 
dictors of subsequent kidney dysfunction in this model. 
Serum albumin level, serum sodium level, mean arterial 
pressure, serum creatinine level, PT and encepha- 
lopathy were not significant in this analysis. The 
estimated survival function-type curves for kidney dys- 
function based on RI values while controlling for 
covariants are shown in Figure 2. 
Hepatorenal syndrome developed in 21 patients (12%) 
of our study population. The mean follow-up time for all 
patients was 263 days, and the mean time for devel- 
opment of the hepatorenal syndrome was 63 days. In the 
patients in whom hepatorenal syndrome developed, the 
mean initial RI was 0.77 & 0.05, which was significantly 
higher than that in patients in whom the hepatorenal 
syndrome did not develop (0.67 * 0.07) (p < 0.01). 
Subsequent development of hepatorenal syndrome was 
TABLE 2. Relationship of renal RI at presentation to 
development of hepatorenal syndrome in 180 nonazotemic 
patients with liver disease 
Status Normal RI ( c 0.70) Elevated RI ( 2 0.70) Total 
No HRS 103 56 159 
HRS 1 20 21 
HRS, hepatorenal syndrome. 
The association between RI and subsequent development of 
hepatorenal syndrome was statistically significant (p < 0.001). 
significantly related to renal RI status as indicated by 
Table 2. Twenty of the 21 patients in whom hepatorenal 
syndrome subsequently developed had an elevated RI at 
presentation (Fig. 3). Hepatorenal syndrome developed 
in 26% (20/76) of patients with an elevated RI, whereas 
only 1% (1/104) of patients with a normal renal RI went 
on to have hepatorenal syndrome. Hepatorenal syn- 
drome development was an ominous prognostic sign 
because 17 of these 21 patients died. For all 180 patients, 
survival to either death or liver transplantation for 4 mo 
from the date of renal Doppler examination was ob- 
served in 99% of patients with a normal renal RI but in 
only 75% of those with an elevated RI (p < 0.01). 
Cox regression analysis was performed for the 
outcome of hepatorenal syndrome with the individual 
parameters assessed in this study. Renal RI was a highly 
significant predictor of subsequent hepatorenal syn- 
drome development (p < 0.00005). Serum bilirubin 
level (p < 0.05) and PT (p < 0.05) were also significant 
predictors of hepatorenal syndrome in this model. 
Serum albumin and sodium levels, ascites, encepha- 
lopathy, mean arterial pressure, serum creatinine con- 
centration and age were not significantly related to 
subsequent hepatorenal syndrome development. 
The mean RI value for the patients in whom the 
hepatorenal syndrome developed (0.77 k 0.05) was sig- 
nificantly higher than for the 27 patients in whom 
kidney disease not classified as hepatorenal syndrome 
developed (mean RI, 0.72 -t 0.04) (p < 0.05) and the 
132 patients who had no kidney dysfunction (mean RI, 
0.65 2 0.08) (p < 0.01). Patients with kidney disease 
but without the hepatorenal syndrome had a signifi- 
cantly higher initial renal RI value than patients 
without subsequent kidney dysfunction (p < 0.05). 
Cause of liver disease was not a significant factor 
affecting the RI value. For each disease group the mean 
RI was between 0.66 and 0.70 with no statistically 
significant differences between diagnostic categories. 
Elevated RIs were seen more commonly in decompen- 
sated patients. An elevated RI was observed in 4 of 32 
(12%) Child-Pugh class A patients, 35 of 89 (39%) class 
B patients and 37 of 59 (63%) class C patients. 
Although an elevated RI was more commonly seen 
with more advanced liver disease as shown by 
Child-Pugh class, the RI did not merely reflect the 
degree or decompensation of liver function (Table 3). 
This point is well illustrated by data for the subgroup of 
Child-Pugh class C patients highlighted in Table 4. 
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FIG. 3. Abnormal renal Doppler waveform (RI, 0.84) in a patient who was clinically nonazotemic (creatinine level, 1.0 mgidl). Hepatorenal 
syndrome developed in this patient 8 wk later. 
TABLE 3. Relationship between severity of liver disease, RI and kidney outcome in 180 patients 
HRS RD 
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HRS, Hepatorenal syndrome; RD, laboratory evidence for kidney dysfunction (see text) 
"Percentage of patients in the subclassification in whom the finding developed. 
Despite similar Child-Pugh scores, the subsequent 
kidney outcome was considerably worse in those pa- 
tients with an elevated RI, in whom kidney dysfunction 
and hepatorenal syndrome occurred in 78% and 4396, 
respectively, compared with 14% and 092, respectively, in 
those Child-Pugh class C patients in whom the renal RI 
was normal. 
Although the patients with an initially elevated 
creatinine level were excluded from the primary focus of 
this study, data analysis revealed a mean RI of 0.77 in 
these 67 patients with all but 11 patients having an 
elevated RI. The hepatorenal syndrome did not develop 
in any of the 11 patients with a normal RI but an 
elevated creatinine level, and the creatinine level sub- 
sequently decreased to normal in 9 of these 11. 
DISCUSSION 
The hepatorenal syndrome is a well-recognized com- 
plication of liver failure that often appears to develop 
acutely in previously nonazotemic patients (1). The 
earliest stages of this apparently functional form of 
kidney failure often go unrecognized because creatinine 
elevation is a late feature of the hepatorenal syndrome 
spectrum (1-3). Intense intrarenal vasoconstriction is an 
early hallmark of this functional kidney failure, al- 
though the precise causes are poorly defined and clinical 
assessment of the vasoconstriction has up to now been 
difficult (8-11). We have applied renal duplex Doppler 
ultrasonography, a widely available noninvasive mo- 
dality, to the identification of this early kidney vasocon- 
striction in nonazotemic patients with established liver 
disease. Through use of a simply measured and easily 
obtained parameter, the RI, patients with probable 
kidney vasoconstriction can be quickly identified. We 
hypothesized that these patients with an elevated RI 
(presumably reflecting intrarenal vasoconstriction) 
would be at greater risk for development of overt 
hepatorenal syndrome. We have found renal RI to be a 
useful new noninvasive predictor of subsequent kidney 
status in nonazotemic patients with liver disease. 
We analyzed our data for a poor kidney outcome, 
which we termed kidney dysfunction (doubling of initial 
creatinine level to at least 1.5 mg/dl). This outcome 
variable encompasses the patients with hepatorenal 
HEPATOLOGY Vol. 20, NO. 2, 1994 PLATT ET AL. 367 
TABLE 4. Comparison of parameters and outcomes in 59 Child-Pugh class C patients categorized by renal R1 
Parameters Normal RI p Value Elevated RI 
No. of patients 22 37 
Bilirubin (mg/dl)"~* 7.0 r+_ 6.3 NS 8.2 t 7.5 
Creatinine (mg/dl)",' 0.9 ? 0.3 NS 1.0 ? 0.2 
Albumin (gm/dl)" 2.6 ? 0.4 NS 2.7 -t 0.5 
PT (set)" 15.6 ? 1.6 NS 16.4 rt_ 2.1 
11.2 -e 1.1 Child-Pugh scorea 10.5 c 1.0 NS 
HRS (96)" 0 < 0.001 43 (16/37) 
RD (%Id 14 (3/22) < 0.001 78 (29/37) 
N S ,  Not significant; HRS, hepatorenal syndrome; RD, laboratory evidence for rend dysfunction. 
"Data expressed as mean rt_ S.D. 
*To convert bilirubin to micromoles per liter multiply by 17.1. 
'To convert values for creatinine to micromoles per liter multiply by 88.4. 
"Numbers in parentheses are numbers of patients. 
syndrome and adds patients in our series who had often 
significant kidney failure that did not meet formal 
criteria for hepatorenal syndrome during the time of 
study. Prior reports have identified an elevated creat- 
inine level to be a very important risk factor for 
morbidity and mortality, both before and after liver 
transplantation (19, 21, 22). In our study of patients 
with a normal serum creatinine level, kidney dys- 
function developed in 27% (48/180), 42 (88%) of whom 
had an elevated renal RI. In contrast, only 6% (6/104) of 
patients with a normal RI had kidney dysfunction. RI 
was a significant independent predictor of subsequent 
kidney dysfunction, on the basis of Cox regression 
analysis. 
Hepatorenal syndrome developed in 12% (21/180) of 
our study group. An elevated renal RI was observed at a 
time when serum creatinine level was within normal 
limits in 95% (20/21) of patients in whom hepatorenal 
syndrome later developed. Hepatorenal syndrome de- 
veloped in only 1% (1/104) of patients with a normal 
renal RI. Therefore, those patients with a normal RI, 
which presumably indicated the lack of pathologic 
vasoconstriction, were at very small risk for overt 
hepatorenal syndrome. Interestingly, the one patient 
with a normal renal RI in whom hepatorenal syndrome 
developed was observed again and found to have a 
markedly elevated RI (0.84) at the time of clinical 
hepatorenal syndrome. The time interval between initial 
Doppler study and hepatorenal syndrome in this patient 
was 220 days, and it is possible that this patient also had 
an elevated RI long before presenting with overt hepa- 
torenal syndrome. 
For the prediction of hepatorenal syndrome we com- 
pared RI with the components of the Child-Pugh 
classification (20), serum creatinine level, serum sodium 
level, mean arterial pressure and patient age. We found 
RI to be a significant independent prognostic variable of 
subsequent hepatorenal syndrome by Cox proportional 
hazards regression analysis. 
Although almost all patients in whom hepatorenal 
syndrome developed and most in whom kidney dys- 
function developed had an elevated renal RI, not all 
patients with an elevated RI had a poor kidney outcome. 
Prior clinical reports suggest that functional kidney 
failure and vasoconstriction are much more prevalent 
than overt hepatorenal syndrome (2, 8, 23-25). It is 
therefore possible that an additional insult such as 
sepsis, bleeding, excessive diuresis or nephrotoxic drug 
administration is necessary to hasten the development 
of clinical hepatorenal syndrome among the group of 
at-risk patients (those already with renal vasocon- 
striction reflected by an elevated RI). 
The relationship between severity of liver disease, 
renal RI and clinical kidney outcome is illustrated in 
Table 3. Although the severity of liver disease is related 
to observed RI, with RI elevation much more common in 
class C than class A patients, it would be a mistake to 
consider the RI as merely providing repetitive infor- 
mation to traditional parameters. This point is high- 
lighted by data in Table 4 showing RI to be a useful 
predictor of kidney outcome among the patients with the 
most severe liver disease (Child class C). Hepatorenal 
syndrome did not develop in any Child-Pugh class C 
patient with a normal RI. Furthermore, patients with 
less severe liver disease (class B) and an  elevated RI had 
more frequent poor kidney outcomes than more decom- 
pensated class C patients with a normal RI (Table 3). 
Combining the clinical and RI data allowed identifi- 
cation of a subgroup of patients (class C and elevated RI) 
a t  highest risk for kidney dysfunction and hepatorenal 
syndrome. 
The cause of liver disease was not a significant 
predictor of observed renal RI. Our data would suggest 
that the early stage of intrarenal vasoconstriction is seen 
broadly across most causes of liver disease because we 
observed almost identical mean RI values for each major 
liver disease category. 
Duplex Doppler ultrasonography is widely available in 
the medical community. The examination is quick and 
noninvasive. In our study the renal Doppler ultrasound 
study was technically successful in all patients; no 
patient had to be excluded because of our inability to 
obtain a RI measurement. At our institution almost all 
patients in whom liver transplantation is considered 
undergo a right upper quadrant ultrasound examination 
with duplex Doppler study of hepatic vasculature. 
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Therefore, the addition of a renal Doppler study would 
take only a few minutes in these patients already in the 
sonography suite. 
Several potential limitations of our study are im- 
portant to consider. First, a number of nonazotemic pa- 
tients (n = 60) initially examined with renal Doppler 
ultrasonography were not included in this study because 
no appropriate follow-up data could be obtained. Al- 
though this exclusion is a possible source of bias, the 
patients so excluded were not selected on the basis of 
Doppler findings, and we believe our resulting study 
population to be representative of the patient population 
being seen in the liver clinics of our institution. These 60 
patients had a similar percentage of elevated RIs (40%) 
as compared with our study population (42%) and a 
similar severity of liver disease (mean Child-Pugh score, 
8.7 -+ 1.8) as compared with our study population (mean 
score, 8.5 2 2.1). In our study, we used serum creatinine 
concentration as an indicator of the patients’ initial 
kidney status. More sophisticated types of kidney evalu- 
ation such as glomerular filtration rate were not used. 
Other kidney pathologic states besides hepatorenal syn- 
drome and functional kidney failure are capable of el- 
evating the RI (12-16). Kidney obstruction, acute tu- 
bular necrosis, renal vein thrombosis and the hemolytic- 
uremic syndrome all can cause RI elevation (12-16). 
However, these patients in general have clinically 
recognized kidney dysfunction accompanying the el- 
evated renal RI, and neither the clinical syndromes nor 
the kidney dysfunction were recognized during evalu- 
ation of the clinically nonazotemic patients in our study. 
Last, this study was not designed to assess changes in 
renal RI over time. Longitudinal data of this type were 
beyond the scope of this initial investigation but may be 
valuable as predictors of impending hepatorenal syn- 
drome. 
In conclusion, we have demonstrated that renal 
duplex Doppler ultrasound examination noninvasively 
identifies a subgroup of nonazotemic patients with 
established liver disease at higher risk for subsequent 
kidney dysfunction and hepatorenal syndrome by pre- 
sumably detecting renal vasoconstriction. An abnormal 
renal RI predicts an increased chance for development of 
the hepatorenal syndrome and kidney dysfunction in- 
dependent of liver disease severity and is a better 
predictor than the individual parameters of the 
Child-Pugh classification. When an elevated RI is ob- 
tained, a formal evaluation for hepatorenal syndrome 
including fluid challenge should be considered. A normal 
renal Doppler study would indicate that hepatorenal 
syndrome is very unlikely. Doppler information will be 
useful for prognosis and in the management of liver 
disease in patients whenever they require paracentesis, 
diuretic therapy, potentially nephrotoxic medications or 
radiographic contrast examination. In the future, renal 
RI monitoring may prove to be valuable in assessing 
therapies designed to maintain normal renal vascular 
tone (26, 27) and in recognizing patients in whom early 
liver transplantation may be desirable. 
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